Rapidly progressive interstitial lung disease due to anti-MDA-5 antibody-positive clinically amyopathic dermatomyositis complicated with cervical cancer: Successful treatment with direct hemoperfusion using polymyxin B-immobilized fiber column therapy
Tài liệu tham khảo
Gerami, 2006, A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis siné myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies, J. Am. Acad. Dermatol., 54, 597, 10.1016/j.jaad.2005.10.041
Hallowell, 2014, Pulmonary manifestations of polymyositis/dermatomyositis, Semin. Respir. Crit. Care Med., 35, 239, 10.1055/s-0034-1371528
Kameda, 2005, Combination therapy with corticosteroids, cyclosporin A, and intravenous pulse cyclophosphamide for acute/subacute interstitial pneumonia in patients with dermatomyositis, J. Rheumatol., 32, 1719
Ichiyasu, 2014, Favorable outcome with hemoperfusion of polymyxin B-immobilized fiber column for rapidly progressive interstitial pneumonia associated with clinically amyopathic dermatomyositis: report of three cases, Mod. Rheumatol., 24, 361, 10.3109/14397595.2013.852847
Sato, 2005, Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis, Arthritis Rheum., 52, 1571, 10.1002/art.21023
Gono, 2010, Clinical manifestation and prognostic factor in anti-melanoma differentiation-associated gene 5 antibody-associated interstitial lung disease as a complication of dermatomyositis, Rheumatology, 49, 1713, 10.1093/rheumatology/keq149
SL1, 2013, The diagnostic utility of autoantibodies in adult and juvenile myositis, Curr. Opin. Rheumatol., 25, 772, 10.1097/01.bor.0000434664.37880.ac
Hoshino, 2010, Anti-MDA5 and anti-TIF1-gamma antibodies have clinical significance for patients with dermatomyositis, Rheumatology, 49, 1726, 10.1093/rheumatology/keq153
Muro, 2012, Disappearance of anti-MDA-5 autoantibodies in clinically amyopathic DM/interstitial lung disease during disease remission, Rheumatology, 51, 800, 10.1093/rheumatology/ker408
Fiorentino, 2011, The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study, J. Am. Acad. Dermatol., 65, 25, 10.1016/j.jaad.2010.09.016
Tsushima, 2007, Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome, Ther. Apher. Dial., 11, 138, 10.1111/j.1744-9987.2007.00415.x
Abe, 2012, Polymyxin B-immobilized fiber column (PMX) treatment for idiopathic pulmonary fibrosis with acute exacerbation: a multicenter retrospective analysis, Intern Med., 51, 1487, 10.2169/internalmedicine.51.6965
Ronco, 2014, Polymyxin B hemoperfusion: a mechanistic perspective, Crit. Care, 18, e309, 10.1186/cc13912
Cruz, 2014, New trends in polymyxin B hemoperfusion: from 2006 to 2013, Blood Purif., 37, 9, 10.1159/000356986
Zou, 2016, Serum IL8 and mRNA level of CD11b in circulating neutrophils are increased in clinically amyopathic dermatomyositis with active interstitial lung disease, Clin. Rheumatol., 35, 117, 10.1007/s10067-015-3080-1
Chen, 2013, Utility of anti-melanoma differentiation-associated gene 5 antibody measurement in identifying patients with dermatomyositis and a high risk for developing rapidly progressive interstitial lung disease: a review of the literature and a meta-analysis, Arthritis Care Res., 65, 1316, 10.1002/acr.21985
Trallero-Araguás, 2012, Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis, Arthritis Rheum., 64, 523, 10.1002/art.33379
Kumar, 2014, Paraneoplastic dermatomyositis with carcinoma cervix: a rare clinical association, Case Rep. Dermatol. Med., 836246
Molina-Ruiz, 2015, Amyophatic dermatomyositis presenting as a flagellated skin eruption with positive MDA5 antibodies and thyroid cancer: a real association?, Clin. Exp. Dermatol., 40, 887, 10.1111/ced.12674
Yamaoka, 2014, Anti-MDA5 antibody-positive dermatomyositis with lethal progressive interstitial lung disease and advanced gastric cancer, Eur. J. Dermatol., 24, 490, 10.1684/ejd.2014.2381